Lidocaine metabolite formation in the liver donor as a predictive test for the safe and efficient introduction of cyclosporine in the recipient.
Azoulay
D
D
Hepatobiliary Surgery and Liver Transplant Research Unit, Paul Brousse Hospital, Villejuif, France.
Lemoine
A
A
Gries
J M
JM
Adam
R
R
Dolizy
I
I
Fredj
G
G
Beaune
P
P
Bismuth
H
H
D000293:Adolescent; D000328:Adult; D000368:Aged; D001926:Brain Death; D002648:Child; D016572:Cyclosporine / Q000627:therapeutic use*; D003577:Cytochrome P-450 Enzyme System / Q000032:analysis; D005260:Female; D006801:Humans; D007527:Isoenzymes / Q000032:analysis; D008012:Lidocaine / Q000031:analogs & derivatives* / Q000097:blood; D008099:Liver / Q000378:metabolism*; D008111:Liver Function Tests; D016031:Liver Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D014019:Tissue Donors
D007527:Isoenzymes; D016572:Cyclosporine; D003577:Cytochrome P-450 Enzyme System; D008012:Lidocaine; C001173:monoethylglycinexylidide